The biggest construction trade show in North America returns, and with it comes no shortage of new products, equipment, and technology.
Recursion is using AI to develop new drug candidates much more efficiently than the overall industry. Tempus AI's $1.27 billion trailing revenue comes from a clinical data flywheel that no competitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results